Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clinitech LaboratoryBOM:544220 -7.50%38 OCF Yield % is -9.39 as of Aug. 24, 2026. GuruFocus rates BOM:544220 with a GF Score™ of 38/100. The stock has 6 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Clinitech Laboratory ranks worse than 76.53% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Clinitech Laboratory's OCF Yield % or its related term are showing as below:
BOM:544220'
s OCF Yield % Range Over the Past 10 Years
Min: -13.95 Med: -9.23 Max: -4.89
Current: -9.39
During the past 6 years, the highest OCF Yield % of Clinitech Laboratory was -4.89%. The lowest was -13.95%. And the median was -9.23%.
BOM:544220's OCF Yield % is ranked worse than 76.53% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.36
vs BOM:544220: -9.39
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Clinitech Laboratory OCF Yield % Related Terms
Clinitech Laboratory OCF Yield % Historical Data
* Premium members only.
The historical data trend for Clinitech Laboratory's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544220 vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Clinitech Laboratory's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinitech Laboratory OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clinitech Laboratory's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Clinitech Laboratory's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinitech Laboratory (BOM:544220) has a OCF Yield % of -9.39 as of Aug. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Clinitech Laboratory and its competitors. According to the industry distribution chart, Clinitech Laboratory ranks #163 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 76.5%.
Is Clinitech Laboratory's OCF Yield % too high?
Clinitech Laboratory's current OCF Yield % is -9.39. Based on the distribution chart, Clinitech Laboratory ranks #163 out of 213 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Clinitech Laboratory has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Clinitech Laboratory's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinitech Laboratory ranks #163 out of 213 companies for OCF Yield %. This places Clinitech Laboratory in the lower half of its industry. The industry median OCF Yield % is 1.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.36, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Clinitech Laboratory and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinitech Laboratory's current OCF Yield % is -9.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinitech Laboratory stock overvalued right now?
Clinitech Laboratory (BOM:544220) has a current OCF Yield % of -9.39. The current OCF Yield % is -9.39. Clinitech Laboratory's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Clinitech Laboratory (BOM:544220), the current OCF Yield % is -9.39 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Clinitech Laboratory Ltd is an Indian diagnostic and healthcare services provider company. It operates a network of diagnostic centers in Thane and Navi Mumbai and offers various medical tests across multiple specialties, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology. It serves individual patients as well as corporate clients, aiming to provide affordable and comprehensive diagnostic solutions.
38GF Score
Get the complete analysis for BOM:544220
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544220 has been successfully added to your 
